Humoral immune response in multiple sclerosis patients followingPfizerBNT162b2 COVID19 vaccinationdekel harariOct 18, 20210 min readUpdated: Jan 20, 20221-s2.0-S0165572821002733-main.pdfDownload PDF • 1.67MB
Comments